Assessment of long-term efficacy and safety of metyrapone monotherapy in a patient with ACTH-independent macronodular adrenal hyperplasia.
Masanori
M
Yoshida
Hiroshi
H
Umeda
Shintaro
S
Iwama
Seiko
S
Nakayama
Misaki
M
Miyata
Koichiro
K
Ogawa
Harumi
H
Maeda
Yutaka
Y
Oiso
D000311:Adrenal Glands / Q000473:pathology* / Q000503:physiopathology; D000324:Adrenocorticotropic Hormone / Q000502:physiology*; D000368:Aged; D003480:Cushing Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006965:Hyperplasia; D008797:Metyrapone / Q000009:adverse effects* / Q000627:therapeutic use*; D013252:Steroid 11-beta-Hydroxylase / Q000037:antagonists & inhibitors; D016896:Treatment Outcome
D004791:Enzyme Inhibitors; D000324:Adrenocorticotropic Hormone; D013252:Steroid 11-beta-Hydroxylase; D008797:Metyrapone